Results 151 to 160 of about 1,543,622 (248)

A literature review on the analysis of symptom-based clinical pathways: Time for a different approach? [PDF]

PLOS Digit Health, 2022
Gunatilleke NJ, Fleuriot J, Anand A.
europepmc   +1 more source

Effectiveness of a Clinical Pathway for Emergency Management of Pediatric Asthma [PDF]

, 2003
SP Norton, Martin Pusic, F. Taha, S Heathcote   +3 more
openalex   +1 more source

LINC01116, a hypoxia‐lncRNA marker of pathological lymphangiogenesis and poor prognosis in lung adenocarcinoma

Molecular Oncology, EarlyView.
The LINC01116 long noncoding RNA is induced by hypoxia and associated with poor prognosis and high recurrence rates in two cohorts of lung adenocarcinoma patients. Here, we demonstrate that besides its expression in cancer cells, LINC01116 is markedly expressed in lymphatic endothelial cells of the tumor stroma in which it participates in hypoxia ...
Marine Gautier‐Isola, Rafael Lopes Goncalves, Marin Truchi, Caroline Lacoux, Célia Scribe, Hugo Cadis, Laetitia Guardini, Sophie Bekisz, Marius Ilié, Paul Hofman, Georges Vassaux, Bernard Mari, Roger Rezzonico   +12 more
wiley   +1 more source

A thematic analysis of the views of neurodivergent women with a personality disorder diagnosis on clinical pathways within mental health services. [PDF]

Discov Ment Health
Graham R, Matthews Z, Parker J, Dyer T, Cullinane H, Crole-Rees C.   +5 more
europepmc   +1 more source

Experiences of using clinical pathways in hospitals: Perspectives of quality improvement personnel. [PDF]

Nurs Open, 2023
Hwang JI, Tchoe HJ, Chung S, Park E, Choi M.   +4 more
europepmc   +1 more source

ATF4‐mediated stress response as a therapeutic vulnerability in chordoma

Molecular Oncology, EarlyView.
We screened 5 chordoma cell lines against 100+ inhibitors of epigenetic and metabolic pathways and kinases and identified halofuginone, a tRNA synthetase inhibitor. Mechanistically halofuginone induces an integrated stress response, with eIF2alpha phosphorylation, activation of ATF4 and its target genes CHOP, ASNS, INHBE leading to cell death ...
Lucia Cottone, James Dunford, Eleanor Calcutt, Vicki Gamble, Filiz Senbabaoglu Aksu, Lorena Ligammari, Georgina Wherry, Giorgia Gaeta, John C. Christianson, Adrienne M. Flanagan, Udo Oppermann, Adam P. Cribbs   +11 more
wiley   +1 more source

Clinical Pathways in Knee and Hip Arthroplasty: Narrative Review on Sustainability, Quality, and Resource Management. [PDF]

JMIR Perioper Med
Godinho M, Maçães F, Gonçalves H, Silva F.   +3 more
europepmc   +1 more source

Personalising clinical pathways in a London breast cancer service. [PDF]

Sociol Health Illn, 2022
Viney W, Day S, Bruton J, Gleason K, Ion C, Nazir S, Ward H.   +6 more
europepmc   +1 more source

A subset of MMR‐proficient colon cancers responds to neoadjuvant immunotherapy

Molecular Oncology, EarlyView.
Tan et al. reveal that a distinct subset of early‐stage pMMR colon cancers can respond to neoadjuvant immunotherapy. In the NICHE‐2 trial, responders (26%) were characterized by chromosomal instability, TP53 mutations, and proliferative cell‐cycle programs, whereas nonresponders showed metabolic and stromal reprogramming with TGF‐β‐driven ...
Eleonora Piumatti, Giovanni Germano, Pietro Paolo Vitiello, Alberto Bardelli   +3 more
wiley   +1 more source

Development of data-driven clinical pathways: the big data clinical evidence-based pathways. [PDF]

BMJ Health Care Inform
Cui X, Sui M, Xie H, Chen W, Tian W, Wang P, Jiang X, Fu C, Xu S.   +8 more
europepmc   +1 more source